More on UHS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+9.5% Growth)
- Ratings (3.4 Score)
- Holders
- Dividends (0.5% Yield)
- Event Driven Deals

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (7/27/26)
- M&A (12/31/15 *Est)
- M&A (12/31/21 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

UHS Cash Flow Statement

Click line-items for a historical chart and %
Net income 568.43M
Depreciation & amortization 309.17M
Net gain on sale of assets
Stock-based compensation expense 36.36M
Accounts receivable -6.84M
Accrued interest 3.3M
Accrued and deferred income taxes
Other working capital accounts 124.99M
Other assets and deferred charges -11.45M
Other 58.04M
Accrued insurance expense, net of commercial premiums paid
Payments made in settlement of self-insurance claims
Net cash provided by operating activities 1.1B
Property and equipment additions, net of disposals -396.16M
Proceeds received from sale of assets and businesses
Costs incurred for purchase and implementation of electronic health records application
Net cash used in investing activities -532.38M
Reduction of long-term debt -814.97M
Additional borrowings
Financing costs -12.33M
Repurchase of common shares -297.18M
Dividends paid -29.2M
Issuance of common stock 6.38M
Profit distributions to noncontrolling interests -61.05M
Proceeds from sale of noncontrolling interest in majority owned business
Net cash used in financing activities -563.94M
Increase (decrease) in cash and cash equivalents 516K
Cash and cash equivalents, beginning of period 61.23M
Cash and cash equivalents, end of period 61.74M
Interest paid 82.88M
Income taxes paid, net of refunds 259.17M